These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2262878)

  • 1. [Studies on FK482 (Cefdinir). III. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-aryl-2-hydroxyiminoacetamido]-3-vinyl-3- cephem-4-carboxylic acid derivatives].
    Inamoto Y; Sakane K; Kamimura T; Takaya T
    Yakugaku Zasshi; 1990 Sep; 110(9):658-64. PubMed ID: 2262878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on FK482 (Cefdinir). IV. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]- 3-substituted cephalosporin derivatives].
    Inamoto Y; Sakane K; Kamimura T; Takaya T
    Yakugaku Zasshi; 1990 Dec; 110(12):908-15. PubMed ID: 2074536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on FK482. II. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-substituted acetamido]-3-vinyl-3-cephem-4-carboxylic acid derivatives].
    Inamoto Y; Chiba T; Sakane K; Kamimura T; Takaya T
    Yakugaku Zasshi; 1990 Apr; 110(4):246-57. PubMed ID: 2376819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally active cephalosporins. III. Synthesis and structure-activity relationships of new 3-heterocyclicthiomethylthio-7 beta-[(Z)- 2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-cephem-4 -carboxylic acids.
    Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K
    J Antibiot (Tokyo); 1993 Feb; 46(2):316-30. PubMed ID: 8468248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new oral cephem, cefdinir: its structure-activity relationships and biological profile].
    Sakane K; Inamoto Y; Takaya T
    Jpn J Antibiot; 1992 Aug; 45(8):909-25. PubMed ID: 1433897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research and development of new oral cephems, cefixime and cefdinir].
    Sakane K; Kawabata K; Inamoto Y; Yamanaka H; Takaya T
    Yakugaku Zasshi; 1993 Sep; 113(9):605-26. PubMed ID: 8229662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally active cephalosporins. II. Synthesis and structure-activity relationships of new 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-cephalospori ns with 1,2,3-triazole in C-3 side chain.
    Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K; Nakano M
    J Antibiot (Tokyo); 1993 Jan; 46(1):177-92. PubMed ID: 8436551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally active cephalosporins: synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporins.
    Yamamoto H; Terasawa T; Ohki A; Shirai F; Kawabata K; Sakane K; Matsumoto S; Matsumoto Y; Tawara S
    Bioorg Med Chem; 2000 Jan; 8(1):43-54. PubMed ID: 10968263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity of FK482, a new orally active cephalosporin.
    Mine Y; Kamimura T; Watanabe Y; Tawara S; Matsumoto Y; Shibayama F; Kikuchi H; Takaya T; Kuwahara S
    J Antibiot (Tokyo); 1988 Dec; 41(12):1873-87. PubMed ID: 3264828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Orally active cephalosporins. I. Synthesis and structure-activity relationships of 7 beta-[2-(R)-amino-2-phenylacetamido]-3-(1H- 1,2,3-triazol-4-yl)alkylthiomethyl-3-cephem-4-carboxylic acid and related compounds].
    Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K
    Yakugaku Zasshi; 1992 Sep; 112(9):622-37. PubMed ID: 1469610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on cephalosporin antibiotics. IV. Synthesis, antibacterial activity and oral absorption of new 3-(2-substituted-vinylthio)-7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2- (carboxymethoxyimino)acetamido]cephalosporins.
    Yokoo C; Goi M; Onodera A; Fukushima H; Nagate T
    J Antibiot (Tokyo); 1991 Dec; 44(12):1422-31. PubMed ID: 1778793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on beta-lactam antibiotics. XIII. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-aryl-2-carboxymethoxyiminoacetamido]-3-vinylcepha losporins .
    Kawabata K; Yamanaka H; Takasugi H; Takaya T
    J Antibiot (Tokyo); 1986 Mar; 39(3):404-14. PubMed ID: 3700242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on cephalosporin antibiotics. V. Synthesis, antibacterial activity and oral absorption of new 3-[(Z)-2-methoxycarbonylvinylthio]-7 beta- [(Z)-2-(2-aminothiazol-4-yl)-2-(oxyimino)acetamido]cephalosporins.
    Yokoo C; Onodera A; Fukushima H; Numata K; Nagate T
    J Antibiot (Tokyo); 1992 Jun; 45(6):932-9. PubMed ID: 1500361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthetic cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(O-substituted oxyimino)acetamido]-3-(1,2,3-triazol-1-yl)methyl-3-cephem-4-carboxylic acid and related compounds].
    Sakagami K; Sakai M; Kashi T; Ishimaru T
    Yakugaku Zasshi; 1989 Dec; 109(12):957-61. PubMed ID: 2630639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on cephalosporin antibiotics. III. Synthesis, antibacterial activity and oral absorption of new 3-(substituted-alkylthio)-7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2- (carboxymethoxyimino)acetamido]cephalosporins.
    Yokoo C; Goi M; Onodera A; Murata M; Nagate T; Watanabe Y
    J Antibiot (Tokyo); 1991 May; 44(5):498-506. PubMed ID: 2061193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on cephalosporin antibiotics. VI. Synthesis, antibacterial activity and oral efficacy in mice of new 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)-acetamido]-3- (substituted alkylthio)cephalosporins.
    Yokoo C; Onodera A; Fukushima H; Numata K; Nagate T
    J Antibiot (Tokyo); 1992 Sep; 45(9):1533-9. PubMed ID: 1429240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally active cephalosporins. Part 4: synthesis, structure--activity relationships and oral absorption of novel 3-(4-pyrazolylmethylthio)cephalosporins with various C-7 side chains.
    Yamamoto H; Eikyu Y; Okuda S; Kawabata K; Takasugi H; Tanaka H; Matsumoto S; Matsumoto Y; Tawara S
    Bioorg Med Chem; 2002 May; 10(5):1535-45. PubMed ID: 11886815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2- aminothiazol-4-yl)-3-(substituted)-2-propenoylamino]-3-cephems with C-3 substitutions.
    Ishikura K; Kubota T; Minami K; Hamashima Y; Nakashimizu H; Motokawa K; Kimura Y; Miwa H; Yoshida T
    J Antibiot (Tokyo); 1994 Apr; 47(4):466-76. PubMed ID: 8195047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of a new cephalosporin, BMY-28232 and its prodrug-type esters for oral use.
    Kamachi H; Narita Y; Okita T; Abe Y; Iimura S; Tomatsu K; Yamasaki T; Okumura J; Naito T; Oki T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1602-16. PubMed ID: 3198494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthetic cephalosporins. V. Synthesis and antibacterial activity of 3-alkylthio-7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(O-substituted oxyimino)acetamido]cephalosporins and related compounds].
    Sakagami K; Watanabe T; Fukatsu S; Nitta H; Hatanaka M; Ishimaru T
    Yakugaku Zasshi; 1989 Dec; 109(12):913-25. PubMed ID: 2698417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.